Study on Dosage Regimens of Asthma Medications in Pediatric Patients of Dr. M. Djamil Padang Hospital

Main Article Content

Rahmi Yosmar
Meri Andani
Helmi Arifin

Abstract

                   A study on dosage regimens of asthma medications in pediatric patients hospitalized at the pediatrics ward DR. M. Djamil Padang hospital has been carried out. The purpose of this study was to determine and compare the suitability of dosage regimen given to pediatric patients in the pediatrics ward of Dr. M. Djamil Padang hospital with the literature. This study was conducted retrospectively with consecutive sampling technique. Samples were obtained from medical records during 2013. The results showed that the appropriate dosage administration of asthma medication for the prednisone, Combivent® and ambroxol were 100%, salbutamol 75%, and theophylline 0%. On the other hand, the entire medications showed 100% suitability concerning the route of administration. While for the interval of administration, the study showed that dexamethasone, prednisone, salbutamol, theophylline and ambroxol were 100% appropriate, but Combivent® was lower at 95.24%. The study concludes that the dose and interval of administration are not in accordance with the literature, while the route of administration is considered to be in accordance with the literature.

Article Details

How to Cite
Yosmar, R., Andani, M., & Arifin, H. (2015). Study on Dosage Regimens of Asthma Medications in Pediatric Patients of Dr. M. Djamil Padang Hospital. Jurnal Sains Farmasi & Klinis, 2(1), 22–29. https://doi.org/10.29208/jsfk.2015.2.1.48
Section
Research Articles

References

Global Initiative for Asthma (GINA). (2011). Global Strategy for Ashtma Management and Prevention. Cape Town: University of Cape Town Lung Institute.

Centers for Disease Control and Prevention (CDC). (2011). Vital Signs: Asthma Prevalence, Disease Characteristic, and Self-Management Education United States 2001 - 2009. Morbidity and Mortality Weekly Report. 60(17), 547-52.

Depkes RI. (2007b). Pharmaceutical Care untuk Penyakit Asma. Jakarta, Departemen Kesehatan Republik Indonesia.

Imelda, S., Faisal, Y., & Wiwien, H.W. (2007). Hubungan Derajat Asma dengan Kualitas Hidup yang Dinilai dengan Asthma Quality of Life Questionnaire. Majalah Kedokteran Indonesia, 57(12), 435-445.

Barnes, NC., Crompton, GK. (1999). Pulmonary Disease. London, McGraw-Hill.

National Heart Lung and Blood Institute (NHLBI). (2002). Difinition. In: Global Initiative for Asthma.

Depkes RI. (2008). Riset Kesehatan Dasar. Perhimpunan Dokter Paru Indonesia (PDPI). Jakarta, Departemen Kesehatan Republik Indonesia.

Afdal, Yani, FF., Basir, D. (2009). Faktor Resiko Asma pada Murid Sekolah Dasar Usia 6-7 tahun di Kota Padang Berdasarkan Kuisioner International Study of Asthma and Allergies in Childhood yang Dimodifikasi. Padang, Departemen of Child Health,Faculty of Medicine, Andalas University.

Mangunnegoro, H. (1991). Diagnosa Penatalaksanaan Asma. Cermin Dunia Kedokteran. (69), 50-54.

Yunus, F. (1992). Prinsip Dasar dan Peranan Terapi Inhalasi. Medika, 18(1), 25-31.

Chung, KF., Clark TIH. (1992). Corticosteroids. In: Asthma 3rd ed. Clark, Goffrey and Lee. London, Chapman & Hall Medical, 416–48.

Rahajo, N. (2004). Pedoman Nasional Asma Anak. UKK Pulmonologi PP IDAI. UKK Pulmonologi.

Tjay, T. H., dan Rahardja, K. (2007). Obat-Obat Penting Khasiat, Penggunaan, dan Efek-Efek Sampingnya Edisi ke VI. Jakarta, PT Elex Media Komputindo.

Depkes RI. (2007a). Pelayanan Informasi Obat. Jakarta, Depkes RI.

Ari, E., Azalia Arif. (2008). Obat Lokal. In Farmakologi dan Terapi. Edisi V. Jakarta, Balai Penerbit Fakultas Kedokteran Universitas Indonesia.

Rowley, S., Asher, I., & Cooper, D. Salbutamol. (2003). 2, (2 screens).

Dipiro, J.T., Robert, L.T., Gary, C.Y., Gary, R.M., Barbara, G.W., L.Michael, P. (2008). Pharmacotherapy: A Pathophysiologic Approach Seventh Edition. USA, The Mc. Graw Hill Company Page.